Predictive Oncology Inc.
General ticker "POAI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $121.2M (TTM average)
Predictive Oncology Inc. does not follow the US Stock Market performance with the rate: -19.7%.
Estimated limits based on current volatility of 5.0%: low 5.28$, high 5.84$
Factors to consider:
- Total employees count: 34 (0.0%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Dependence on key management, Regulatory and compliance, Market competition, Market disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.05$, 17.12$]
- 2025-12-31 to 2026-12-31 estimated range: [5.48$, 17.23$]
Financial Metrics affecting the POAI estimates:
- Negative: with PPE of -4.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -18.43 <= 0.33
- Positive: Investing cash flow per share per price, % of 0.03 > -0.66
- Positive: Return on assets ratio (scaled to [-100,100]) of 68.59 > 6.04
- Negative: Shareholder equity ratio, % of -4.07 <= 18.93
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
- Positive: 0 < Industry operating cash flow per share per price (median), % of 0.78
Short-term POAI quotes
Long-term POAI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.51MM | $1.63MM | $1.62MM |
| Operating Expenses | $27.54MM | $13.75MM | $12.56MM |
| Operating Income | $-26.03MM | $-12.12MM | $-10.94MM |
| Non-Operating Income | $0.30MM | $0.10MM | $0.08MM |
| R&D Expense | $0.00MM | $0.12MM | $0.03MM |
| Income(Loss) | $-25.74MM | $-12.02MM | $-10.86MM |
| Profit(Loss)* | $-25.74MM | $-13.98MM | $-12.20MM |
| Stockholders Equity | $21.77MM | $8.27MM | $-0.20MM |
| Inventory | $0.43MM | $0.48MM | $0.39MM |
| Assets | $25.73MM | $14.42MM | $4.97MM |
| Operating Cash Flow | $-12.37MM | $-13.19MM | $-11.96MM |
| Capital expenditure | $0.48MM | $0.02MM | $0.01MM |
| Investing Cash Flow | $-0.48MM | $-0.30MM | $0.02MM |
| Financing Cash Flow | $6.72MM | $0.15MM | $3.94MM |
| Earnings Per Share** | $-6.98 | $-3.48 | $-2.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.